唾液腺感染症の世界市場レポート 2025年

唾液腺感染症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.1％で60億9,000万米ドルに成長します。この予測期間における成長は、口腔の健康に対する意識の高まり、低侵襲処置の採用拡大、慢性疾患の有病率の増加、ヘルスケアインフラの改善、専門治療への患者アクセスの拡大などに起因すると考えられます。主な動向としては、低侵襲処置の採用、唾液内視鏡技術の発展、高度画像技術の開発、生体適合性ステントの革新、ロボット支援手術の台頭、標的抗菌療法の使用、AI主導型診断ツールの統合などが挙げられます。

口腔の健康問題の有病率の増加は、今後数年間の唾液腺感染症市場の成長を促進すると予想されます。虫歯、歯肉感染症、その他の口腔関連の問題を含む口腔の健康状態は、口腔衛生状態の悪化、不健康な食習慣、歯科治療へのアクセス制限のために増加傾向にあります。これらの問題は、細菌の増殖を促し、唾液管の閉塞を引き起こすことによって、唾液腺感染症のリスクを高める一因となっています。例えば、2024年5月、英国の政府機関である国民保健サービス（NHS）は、2022-23年に3,250万件の歯科治療が行われ、前年比23.2％増であったと報告しました。その結果、口腔の健康問題の有病率の増加が唾液腺感染症市場の拡大を煽っています。

唾液腺感染症市場の企業は、治療結果の改善、患者の回復の促進、ヘルスケア効率の向上のため、特に低侵襲手技の技術的進歩に注力しています。低侵襲手技は、より小さな切開と特殊な道具を使用し、組織損傷を軽減し、より早い治癒を促進します。例えば、2024年3月、インドのヘルスケア機関であるアムリタ病院は、低侵襲唾液腺手術のためのアムリタセンターを立ち上げました。この取り組みでは、手術の必要性を最小限に抑え、唾液腺機能を温存しながら唾液腺疾患を治療する画期的な技術である唾液内視鏡を導入しています。この発表会では、2日間にわたるワークショップが開催され、専門家による手術のデモンストレーションが披露されました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界唾液腺感染症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の唾液腺感染症市場：成長率分析
• 世界の唾液腺感染症市場の実績：規模と成長, 2019-2024
• 世界の唾液腺感染症市場の予測：規模と成長, 2024-2029, 2034F
• 世界唾液腺感染症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の唾液腺感染症市場診断別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単純レントゲン撮影
• 唾液腺造影検査
• コンピュータ断層撮影（CT）
• 磁気共鳴画像法（MRI）
• 放射性核種シンチグラフィー
• 高解像度超音波検査
• その他診断
• 世界の唾液腺感染症市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 手術
• 願望
• ホームケア
• その他の治療法
• 世界の唾液腺感染症市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 医療研究センター
• 学術機関
• その他のエンドユーザー
• 世界の唾液腺感染症市場、単純X線撮影の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 唾液腺のX線写真
• X線による唾液造影検査
• 世界の唾液腺感染症市場唾液腺造影法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 従来の唾液腺造影検査
• デジタルサブトラクション唾液腺造影法（DSS）
• 世界の唾液腺感染症市場、コンピュータ断層撮影（CT）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非造影CT
• 造影CT
• 世界の唾液腺感染症市場磁気共鳴画像法（MRI）のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造影剤なしのMRI
• 造影MRI（ダイナミックMRI）
• 世界の唾液腺感染症市場放射性核種シンチグラフィーの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 平面シンチグラフィー
• SPECT（単一光子放出コンピュータ断層撮影）
• 世界の唾液腺感染症市場高解像度超音波検査のサブセグメンテーション（種類別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準的な超音波検査
• ドップラー超音波検査
• 世界の唾液腺感染症市場、その他の診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細針吸引（FNA）生検
• 内視鏡検査
• 唾液流量検査

第7章 地域別・国別分析

• 世界の唾液腺感染症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の唾液腺感染症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 唾液腺感染症市場：競合情勢
• 唾液腺感染症市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Gilead Sciences, Inc.
• Amgen Inc.
• FUJIFILM Holdings Corporation
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Astellas Pharma Inc.
• Sandoz International GmbH
• Vertex Pharmaceuticals Incorporated
• Incyte Corporation.
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceuticals, Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 唾液腺感染症市場2029：新たな機会を提供する国
• 唾液腺感染症市場2029：新たな機会を提供するセグメント
• 唾液腺感染症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Salivary gland infections are bacterial or viral infections affecting the salivary glands, causing symptoms such as swelling, pain, and dry mouth. These infections commonly occur in the major salivary glands, including the parotid, submandibular, and sublingual glands, and may result from blockage, dehydration, or infections such as mumps.

The primary diagnostic methods for salivary gland infections include plain radiography, sialography, computed tomography (CT), magnetic resonance imaging (MRI), radionuclide scintigraphy, high-resolution ultrasonography, and other techniques. Plain radiography is an imaging method that uses X-rays to visualize internal body structures, including the salivary glands, and is useful for detecting stones or calcifications. Treatment options include medications, surgery, aspiration, home care, and other therapies. These services are provided across hospitals and clinics, medical research centers, academic institutions, and other healthcare settings.

The salivary gland infections market research report is one of a series of new reports from The Business Research Company that provides salivary gland infection market statistics, including the salivary gland infection industry's global market size, regional shares, competitors with a salivary gland infection market share, detailed salivary gland infection market segments, market trends and opportunities, and any further data you may need to thrive in the salivary gland infection industry. This salivary gland infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The salivary gland infection market size has grown strongly in recent years. It will grow from $4.12 billion in 2024 to $4.46 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to the rise in oral health issues, increased awareness of salivary disorders, a growing prevalence of bacterial and viral infections, expanding healthcare infrastructure, a rising geriatric population, and the increased adoption of minimally invasive treatments.

The salivary gland infection market size is expected to see strong growth in the next few years. It will grow to $6.09 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising awareness about oral health, the growing adoption of minimally invasive procedures, an increasing prevalence of chronic conditions, improvements in healthcare infrastructure, and expanded patient access to specialized care. Key trends include the adoption of minimally invasive procedures, advancements in sialendoscopy techniques, the development of advanced imaging technologies, biocompatible stent innovations, the rise of robotic-assisted surgeries, the use of targeted antimicrobial therapies, and the integration of AI-driven diagnostic tools.

The increasing prevalence of oral health issues is expected to drive the growth of the salivary gland infections market in the coming years. Oral health conditions, including tooth decay, gum infections, and other mouth-related problems, are on the rise due to poor oral hygiene, unhealthy eating habits, and limited access to dental care. These issues contribute to a higher risk of salivary gland infections by encouraging bacterial growth and causing blockages in the salivary ducts. For example, in May 2024, the National Health Service (NHS), a UK-based government agency, reported that 32.5 million dental treatments were provided in 2022-23, marking a 23.2% increase compared to the previous year. As a result, the growing prevalence of oral health issues is fueling the expansion of the salivary gland infections market.

Companies in the salivary gland infections market are focusing on technological advancements, particularly in minimally invasive procedures, to improve treatment outcomes, accelerate patient recovery, and enhance healthcare efficiency. Minimally invasive techniques involve smaller incisions and specialized tools, reducing tissue damage and promoting faster healing. For instance, in March 2024, Amrita Hospital, an India-based healthcare institution, launched the Amrita Centre for Minimally Invasive Salivary Gland Surgery. This initiative introduces sialendoscopy, a groundbreaking technique for treating salivary disorders while minimizing the need for surgery and preserving glandular function. The launch featured a two-day workshop showcasing expert demonstrations of the procedure.

In November 2022, Navamedic ASA, a Norway-based pharmaceutical company, acquired the rights and marketing authorizations for clindamycin ready-to-administer bags from ACS Dobfar for an undisclosed sum. This acquisition strengthens Navamedic's product portfolio, increases revenue potential, and reinforces its market presence in the Nordic region. ACS Dobfar, an Italy-based pharmaceutical company, specializes in the development of clindamycin, which is commonly used to treat salivary gland infections.

Major players in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Vanda Pharmaceuticals Inc, Mylan N.V., and Zydus Cadila Healthcare Ltd.

North America was the largest region in the salivary gland infection market in 2024. The regions covered in salivary gland infections report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the salivary gland infections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The salivary gland infections market consists of revenues earned by entities by providing services such as ultrasound, rehabilitation therapy, and glandular duct dilation procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The salivary gland infections market includes sales of antibiotics, antiviral drugs, anti-inflammatory medications, and biocompatible stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Salivary Gland Infection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on salivary gland infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for salivary gland infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The salivary gland infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnosis: Plain Radiography; Sialography; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Radionuclide Scintigraphy; High-resolution Ultrasonography; Other Diagnoses
• 2) By Treatment: Medications; Surgery; Aspiration; Home Care; Other Treatments
• 3) By End User: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other End User
• Subsegments:
• 1) By Plain Radiography: X-ray Of Salivary Glands; Sialography With X-ray
• 2) By Sialography: Conventional Sialography; Digital Subtraction Sialography (DSS)
• 3) By Computed Tomography (CT): Non-contrast CT; Contrast-enhanced CT
• 4) By Magnetic Resonance Imaging (MRI): MRI without contrast; MRI With contrast (Dynamic MRI)
• 5) By Radionuclide Scintigraphy: Planar Scintigraphy; SPECT (Single Photon Emission Computed Tomography)
• 6) By High-resolution Ultrasonography: Standard Ultrasonography; Doppler Ultrasonography
• 7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy; Endoscopy; Salivary Flow Test
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Salivary Gland Infection Market Characteristics

3. Salivary Gland Infection Market Trends And Strategies

4. Salivary Gland Infection Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Salivary Gland Infection Growth Analysis And Strategic Analysis Framework

• 5.1. Global Salivary Gland Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Salivary Gland Infection Market Growth Rate Analysis
• 5.4. Global Salivary Gland Infection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Salivary Gland Infection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Salivary Gland Infection Total Addressable Market (TAM)

6. Salivary Gland Infection Market Segmentation

• 6.1. Global Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plain Radiography
• Sialography
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Radionuclide Scintigraphy
• High-resolution Ultrasonography
• Others Diagnosis
• 6.2. Global Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery
• Aspiration
• Home Care
• Other Treatments
• 6.3. Global Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Medical Research Centers
• Academic Institutes
• Other End User
• 6.4. Global Salivary Gland Infection Market, Sub-Segmentation Of Plain Radiography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-ray Of Salivary Glands
• Sialography With X-ray
• 6.5. Global Salivary Gland Infection Market, Sub-Segmentation Of Sialography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional Sialography
• Digital Subtraction Sialography (DSS)
• 6.6. Global Salivary Gland Infection Market, Sub-Segmentation Of Computed Tomography (CT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-contrast CT
• Contrast-enhanced CT
• 6.7. Global Salivary Gland Infection Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MRI without contrast
• MRI With contrast (Dynamic MRI)
• 6.8. Global Salivary Gland Infection Market, Sub-Segmentation Of Radionuclide Scintigraphy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Planar Scintigraphy
• SPECT (Single Photon Emission Computed Tomography)
• 6.9. Global Salivary Gland Infection Market, Sub-Segmentation Of High-resolution Ultrasonography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Ultrasonography
• Doppler Ultrasonography
• 6.10. Global Salivary Gland Infection Market, Sub-Segmentation Of Other Diagnoses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fine Needle Aspiration (FNA) Biopsy
• Endoscopy
• Salivary Flow Test

7. Salivary Gland Infection Market Regional And Country Analysis

• 7.1. Global Salivary Gland Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Salivary Gland Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Salivary Gland Infection Market

• 8.1. Asia-Pacific Salivary Gland Infection Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Salivary Gland Infection Market

• 9.1. China Salivary Gland Infection Market Overview
• 9.2. China Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Salivary Gland Infection Market

• 10.1. India Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Salivary Gland Infection Market

• 11.1. Japan Salivary Gland Infection Market Overview
• 11.2. Japan Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Salivary Gland Infection Market

• 12.1. Australia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Salivary Gland Infection Market

• 13.1. Indonesia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Salivary Gland Infection Market

• 14.1. South Korea Salivary Gland Infection Market Overview
• 14.2. South Korea Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Salivary Gland Infection Market

• 15.1. Western Europe Salivary Gland Infection Market Overview
• 15.2. Western Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Salivary Gland Infection Market

• 16.1. UK Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Salivary Gland Infection Market

• 17.1. Germany Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Salivary Gland Infection Market

• 18.1. France Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Salivary Gland Infection Market

• 19.1. Italy Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Salivary Gland Infection Market

• 20.1. Spain Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Salivary Gland Infection Market

• 21.1. Eastern Europe Salivary Gland Infection Market Overview
• 21.2. Eastern Europe Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Salivary Gland Infection Market

• 22.1. Russia Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Salivary Gland Infection Market

• 23.1. North America Salivary Gland Infection Market Overview
• 23.2. North America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Salivary Gland Infection Market

• 24.1. USA Salivary Gland Infection Market Overview
• 24.2. USA Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Salivary Gland Infection Market

• 25.1. Canada Salivary Gland Infection Market Overview
• 25.2. Canada Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Salivary Gland Infection Market

• 26.1. South America Salivary Gland Infection Market Overview
• 26.2. South America Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Salivary Gland Infection Market

• 27.1. Brazil Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Salivary Gland Infection Market

• 28.1. Middle East Salivary Gland Infection Market Overview
• 28.2. Middle East Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Salivary Gland Infection Market

• 29.1. Africa Salivary Gland Infection Market Overview
• 29.2. Africa Salivary Gland Infection Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Salivary Gland Infection Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Salivary Gland Infection Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Salivary Gland Infection Market Competitive Landscape And Company Profiles

• 30.1. Salivary Gland Infection Market Competitive Landscape
• 30.2. Salivary Gland Infection Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Salivary Gland Infection Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis AG
• 31.3. GSK plc
• 31.4. Eli Lilly and Company
• 31.5. Gilead Sciences, Inc.
• 31.6. Amgen Inc.
• 31.7. FUJIFILM Holdings Corporation
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Boehringer Ingelheim GmbH
• 31.10. Astellas Pharma Inc.
• 31.11. Sandoz International GmbH
• 31.12. Vertex Pharmaceuticals Incorporated
• 31.13. Incyte Corporation.
• 31.14. Hikma Pharmaceuticals PLC
• 31.15. Lupin Pharmaceuticals, Inc.

32. Global Salivary Gland Infection Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Salivary Gland Infection Market

34. Recent Developments In The Salivary Gland Infection Market

35. Salivary Gland Infection Market High Potential Countries, Segments and Strategies

• 35.1 Salivary Gland Infection Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Salivary Gland Infection Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Salivary Gland Infection Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer